Showing 298 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

HIV prevention policy

The future of antibody-based HIV prevention

Editor's pick
IAVI
10 May 2021
PrEP science

As CROI 2021 Attests, the PrEP Revolution Is Coming

Editor's pick
TheBodyPro
6 April 2021
Injectable & long-acting HIV treatment

Top 5 stories on injectable HIV treatment and prevention from CROI 2021

News
23 March 2021
PrEP science

Low New-HIV Rate With Both Daily and On-Demand PrEP in Paris MSM

Editor's pick
NATAP
17 March 2021
Drug interactions & pharmacokinetics

PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women

News
16 March 2021
PrEP science

Interactions between PrEP and gender-affirming hormone therapy A research briefing

About HIV
March 2021
PrEP science

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

News
10 March 2021
PrEP

Sex, PrEP and HIV in trans and non-binary people A research briefing

About HIV
March 2021
Sexually transmitted infections prevention

Antibiotics to prevent STIs – for or against?

News
10 February 2021
PrEP science

A pill, a ring or a jab: The future of HIV prevention is choice

Editor's pick
Bhekisisa
4 February 2021
Vaginal rings & topical PrEP

Biodegradable TAF Implants Protect 6 of 6 Macaques From Vaginal SHIV

Editor's pick
NATAP
2 February 2021
Injectable & long-acting PrEP

Once-a-month PrEP pill easily passes its first big test

News
27 January 2021
PrEP programmes & uptake

Huge fall in new HIV infections after roll-out of PrEP in Scotland

News
21 January 2021
PrEP science

Periodic PrEP – a new way to take PrEP

Editor's pick
Ending HIV
14 January 2021
Side effects

Meta-analysis finds no real difference in safety and effectiveness between tenofovir formulations

News
5 January 2021
PrEP science

The link between vaginal bacteria and PrEP effectiveness

Editor's pick
Avert
22 December 2020
Injectable & long-acting PrEP

What do we know about injectable PrEP?

About HIV
December 2020
PrEP

PrEP and the trans community webinar

News
10 December 2020
PrEP science

How the vaginal microbiome may affect HIV prevention

Editor's pick
EurekAlert
4 December 2020
HIV treatment

Top 10 HIV Clinical Developments of 2020

Editor's pick
TheBodyPro
1 December 2020
Injectable & long-acting PrEP

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

News
13 November 2020
Injectable & long-acting PrEP

Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women

Editor's pick
World Health Organization
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Injectable & long-acting PrEP

ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women

Editor's pick
ViiV press release
9 November 2020